Five Prime Therapeutics, Inc. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9f1f665b-32f6-4fc8-9bd7-56782a7ed245/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $13.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-014463 |
| FY 2019 | $14.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007407 |
| FY 2018 | $49.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004472 |
| FY 2017 | $39.5M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-004472 |
| FY 2016 | $30.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-004472 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Five Prime Therapeutics, Inc. — all facts · Net Income · Operating Income